Literature DB >> 376540

Activation of human inactive ("pro-") renin by cathepsin D and pepsin.

B J Morris.   

Abstract

Inactive human renin is found in amniotic fluid, plasma, and kidney and may be a renin precursor ("prorenin"). The mechanism of activation of inactive renin in vivo is not known. The present study examined the hypothesis that cathepsin D, a lysosomal pepsin-like endopeptidase may be capable of eliciting activation. Cathepsin D was incubated with inactive renin in human amniotic fluid at pH 4.8 and 22 C for 0-5 h. Marked activation occurred and the reaction displayed first order kinetics with respect to the concentration of cathepsin D. The initial velocity of conversion of inactive renin to active renin by cathepsin D was 0.007%/min/microgram cathepsin D. Under identical conditions, the initial velocity of conversion by pepsin was 0.18%/min/microgram pepsin. The 25-fold higher potency of pepsin compared with cathepsin D is in accordance with the recognized relative substrate affinities and catalytic efficiencies of the two enzymes. Inactive renin in human amniotic fluid seems to be similar to that found in human kidney and since cathepsin D is present in juxtaglomerular cells, this activation process may have physiological importance.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 376540     DOI: 10.1210/jcem-46-1-153

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Conversion between renin and high-molecular-weight renin in the dog.

Authors:  S Funakawa; Y Funae; K Yamamoto
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

2.  Characterization of inactive renin from human kidney and plasma. Evidence of a renal source of circulating inactive renin.

Authors:  W A Hsueh; E J Carlson; V J Dzau
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

Review 3.  The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure.

Authors:  Quanbin Xu; Dane D Jensen; Hua Peng; Yumei Feng
Journal:  Pharmacol Ther       Date:  2016-04-23       Impact factor: 12.310

4.  Circulating prorenin: its molecular forms and plasma concentrations.

Authors:  Kazumi Fujimoto; Sayuki Kawamura; Satoru Bando; Yuji Kamata; Yoshio Kodera; Masayoshi Shichiri
Journal:  Hypertens Res       Date:  2021-02-10       Impact factor: 3.872

5.  Expression of renin-angiotensin system (RAS) components in endometrial cancer.

Authors:  Sarah J Delforce; Eugenie R Lumbers; Celine Corbisier de Meaultsart; Yu Wang; Anthony Proietto; Geoffrey Otton; Jim Scurry; Nicole M Verrills; Rodney J Scott; Kirsty G Pringle
Journal:  Endocr Connect       Date:  2016-12-12       Impact factor: 3.335

Review 6.  The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.

Authors:  Eugenie R Lumbers; Richard Head; Gary R Smith; Sarah J Delforce; Bevyn Jarrott; Jennifer H Martin; Kirsty G Pringle
Journal:  Pharmacol Res Perspect       Date:  2022-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.